Pathogenetic therapy of mitral valve prolapse
Aim. To evaluate the effect of angiotensin II receptor blocker (ARB) therapy on the expression of transforming growth factor-β (TGF-β) in the myxomatous mitral valve, on the serum levels of TGF-β1/TGF-β2 and the left ventricular (LV) systolic function in patients with mitral valve prolapse (MVP).Mat...
Saved in:
Main Authors: | E. G. Malev, S. V. Reeva, M. Yu. Omelchenko, L. B. Mitrofanova, E. V. Timofeev, N. N. Parfenova, E. B. Luneva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2025-02-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/5948 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DIAGNOSTICS AND TREATMENT OF MITRAL VALVE PROLAPSE
by: D. A. Kuzhel, et al.
Published: (2016-01-01) -
Left ventricular function in mitral valve prolapse and severe mitral regurgitation
by: E. G. Malev, et al.
Published: (2013-02-01) -
Mediators of intracellular interactions and endothelial function in myxomatous mitral valve prolapse
by: A. V. Yagoda, et al.
Published: (2013-02-01) -
Case Report: Surgical repair of mitral prolapse caused by papillary muscle elongation using premeasured artificial chordae: a case series
by: Lixi Gan, et al.
Published: (2025-07-01) -
Mitral valve prolapse—arrhythmic faces of the valve disease
by: Maria Możdżan, et al.
Published: (2023-10-01)